Baidu
map

J Sex Med:提高男性性功能的秘诀

2015-03-26 佚名 生物谷

根据发表在Journal of Sexual Medicine杂志上的最新研究表明,不论什么种族,运动均可以使男性有更好的勃起和性功能。 虽然过去的研究已经强调了更好的勃起功能和运动之间的联系,但是在这个文献中非洲裔美国男人人数不足。 "这个研究第一次在种族不同的患者组,将运动的好处与改善的勃起和性功能关联起来,"Cedars-Sinai Samuel Oschin综合癌症所外科系研究人员,这

根据发表在Journal of Sexual Medicine杂志上的最新研究表明,不论什么种族,运动均可以使男性有更好的勃起和性功能。

虽然过去的研究已经强调了更好的勃起功能和运动之间的联系,但是在这个文献中非洲裔美国男人人数不足。

"这个研究第一次在种族不同的患者组,将运动的好处与改善的勃起和性功能关联起来,"Cedars-Sinai Samuel Oschin综合癌症所外科系研究人员,这项研究的主要作者Adriana Vidal说。

近300名研究对象报告了他们自己的活动水平,研究人员将这些活动分为久坐,轻度积极,适度活跃及非常活跃。受试者还报告了自己的性功能,包括勃起能力,性高潮,勃起的质量和频率及总体性功能。

结果发现,不分种族,更频繁运动的男性,每周18代谢当量(METS),有较高的性功能评分。 MET小时数反映了运动的总时间和强度。18 METS可以通过组合不同强度的练习来实现,其等同于,两小时的剧烈运动,如跑步,游泳,3.5小时的适度运动,或6个小时的轻度运动。

相比之下,不分种族,运动少的男性,性功能水平较低。其他引起性功能低下的原因包括糖尿病,高龄,过去或现在吸烟及冠状动脉疾病。

本研究的共同作者,Cedars-Sinai Samuel Oschin 综合癌症研究所,癌症与生活方式综合研究中心主任,Stephen Freedland医师警告说,锻炼应根据每一个人量身定制。

"提到运动,没有一个方法适合于所有人",癌症遗传学和预防项目的联合负责人,Freedland医师说。"不过,我们确信,某种程度的运动,即使强度不大,也比不运动好。"

原始出处

Simon RM1, Howard L, Zapata D, Frank J, Freedland SJ, Vidal AC.The Association of Exercise with Both Erectile and Sexual Function in Black and White Men.J Sex Med. 2015 Mar 20

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2017-06-14 133****4869

    即使强度不大,也比不运动好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-11-07 sanshengshi

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-03-27 xiaoai5777

    没说出什么啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-03-27 yuhuihuiyu

    有点意思。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=210806, encodeId=97ac21080610, content=即使强度不大,也比不运动好, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/30/99bec6cc787188da3751f87718b3f54e.jpg, createdBy=86442053325, createdName=133****4869, createdTime=Wed Jun 14 21:49:29 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42707, encodeId=dfa142e07c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Sat Nov 07 00:15:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606450, encodeId=62791606450f0, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Mar 28 07:40:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18981, encodeId=faae18981af, content=没说出什么啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Fri Mar 27 22:58:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18961, encodeId=9a5d1896159, content=有点意思。, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yuhuihuiyu, createdTime=Fri Mar 27 07:10:00 CST 2015, time=2015-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18914, encodeId=c243189141e, content=还是科学研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 26 16:50:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-03-26 lovetcm

    还是科学研究

    0

相关资讯

ELCC 2014 :专家呼吁重视肺癌患者的性功能障碍

日前,在瑞士日内瓦举行的第四界欧洲肺癌会议(ELCC)上报道的一项研究显示,许多肺癌患者的性表达和性行为遇到了麻烦,然而,这一问题长期以来为研究人员和医生所忽视。研究人员估计,40%到100%的治疗后肺癌患者人群存在性功能障碍问题。研究显示,这一问题会一直存在,而不是随着时间得到自然改善。然而,从目前收集到的大部分资料来看,这一问题与乳腺癌、前列腺癌和妇科癌症相关。而其他癌症如肺癌的这一问题的相关

ASCP 2014:抗抑郁药Brintellix显著改善药物产生的性功能障碍

武田(Takeda)和灵北(Lundbeck)在美国临床精神药理学会(ASCP)2014年年会公布了抑郁症药物Brintellix(vortioxetine)的一项新的头对头研究数据。该研究在接受良好治疗但正经历药物产生的性功能障碍(treatment-emergent sexual dysfunction,TESD)的重度抑郁症(MDD)患者中开展,将Brintellix与艾斯西酞普兰(esci

BJOG:十月怀胎一朝分娩,“性”你还会好吗?

俗话说:“十月怀胎,一朝分娩”。分娩是人类繁衍后代的正常生理过程,也是女性的一种本能。产妇和胎儿都具有潜力能主动参与并完成分娩过程,对于身体健康、年龄适宜、正常足月妊娠的女性来说,阴道分娩是瓜熟蒂落、水到渠成的事。可是临床上很多宝妈会担心,当宝宝从阴道使劲钻出来的那一刻,阴道彻底松弛,“紧握”能力下降,“性”你还会好吗?即使是天使降临的兴奋也掩盖不了这淡淡的

BJU Int.:肥胖或影响男性性功能及泌尿健康

    纽约Presbyterian医院/ Weill Cornell医疗中心的研究人员称,随着男性腰围的增长,其可能更常出现性功能障碍及尿频。这篇发表于8月出版的British Journal of Urology International (BJUI)研究,首次全面显示了男性肥胖不仅对其心脏及代谢方面,还对其性及泌尿健康存在影响。   &n

JOT:骨盆骨折患者生活质量和性功能显著下降

骨盆骨折属于高能量损伤,多发生在交通损伤和高处坠落损伤。急救医学和创伤救治的发展和进步使骨盆骨折的死亡率得到下降,但因骨盆骨折而导致的现场死亡仍高达4%。即使是骨盆骨折得到及时处理,但后期仍存在诸多并发症,例如:慢性疼痛、跛行、性功能及排尿功能障碍等。 泌尿生殖系统(膀胱、尿道、阴道、子宫和前列腺)、腰椎及骶丛神经因临近骨盆骨质而在骨盆骨折的同时而受损,但因此而导致的骨盆骨折晚期并发症例如性

Heart Rhythm: ICD放电对成人先天性心脏病患者性功能的影响

随着植入式心脏转复除颤器(ICD)的问世,越来越多的成人先天性心脏病患者植入ICD用于心源性猝死的一级或二级预防,其主要原因包括越来越多的恶性心律失常被发现及ICD技术的日益成熟。法洛氏四联症患者是需要植入ICD的最大亚群,既往的临床研究已经涉及了ICD植入失败及ICD相关并发症的原因分析,约30%-40%的患者存在ICD的不正确放电。 虽然ICD放电可以拯救患者的生命,但是其带来的心理上的影响

Baidu
map
Baidu
map
Baidu
map